phenacyl moiety compounds 2 and 3 the nitro derivative 3 showed higher activity compared with the dihydroxy derivative 2.
The 3Љ,4Љ-dihydroxyphenacyl derivative 2 revealed significant (pϽ0.5) maximum analgesia at 150 min with a tail flick latency difference (TFLD) value (ϮS.E.M. in seconds) 2.15Ϯ0. 10 of interest that the 3Љ,4Љ-dihydroxyacetophenone derivative 6 of 4-hydroxy-4-phenylpiperidine shows no analgesic activity, 10) when tested for antinociceptive activity in the tail flick test, but produced significant analgesic effect, when examined by a chemical method (writhing test). The only difference between compounds 2 and 6 is the presence of a chlorine atom located at the phenyl ring. This difference led to exhibit strong analgesia. What can be proven by the fact that the writhing test is a simple and sensitive method for screening weak analgesics, whereas the tail flick test is specifically useful for screening strong narcotic analgesia. Compounds 2, 3 and 5 were also screened for their effects on the mean arterial blood pressure in anaesthetized rats. The results are summarized in Table 2 . All compounds tested at doses of 1 mg/kg of body weight intravenously in normotensive rats produced reduction in blood pressure. The onset of depressor responses occurred immediately after administration and the maximal hypotensive effect was produced within 30 s. The duration of responses was 1-3 min. The hypotensive response produced by each of the derivative regained its normal level after 1 min.
Among them, derivative 3 showed maximum hypotensive activity at a dose of 1 mg/kg. Lowering in blood pressure started immediately after intravenous injection and after 20 s, the systolic and diastolic pressures were reduced by 15% and 18%, respectively. Compound 2 also exhibited hypotensive activities at similar levels as compound 3. Minimal blood pressure was recorded at 20 s after administration where the systolic and diastolic pressures decreased by 11% and 12%, respectively. Compound 5 produced the larger falls of systolic pressure (11%) as compared to diastolic pressure (6%). The onset of hypotensive response was immediate and retained for about 3 min.
Conclusion
The present series of compounds were prepared to assess the feasibility of piperidine derivatives with special reference to pethidine as potential analgetic agents.
Experimental
General Melting points were recorded on a Gallenkamp melting point apparatus and are uncorrected. Ultraviolet (UV) spectra were recorded in methanol on a Hitachi U-3200 spectrophotometer. Infrared (IR) spectra were measured on a Shimadzu IR 460 spectrophotometer using KBr discs. Mass spectra (MS) were determined on a MAT 311A spectrophotometer. Elemental analyses were carried out on a Perkin Elmer 2400 CHN elemental analyzer. Nuclear magnetic resonance (NMR) spectra were recorded in DMSOd 6 on a Bruker AM-300 spectrophotometer operating at 300 MHz. Reactions were monitored by TLC using silica gel type 60 F 254 of E. Merck for preparing TLC plates and visualized with iodine vapours.
Analgesic Assay (Tail Flick Test) The analgesic activity of the compounds was tested as antinociceptive effect against thermal stimuli (tail flick test). White male albino mice, weighing 20-30 g, were used for the thermal test. The animals were kept under standard colony condition (12 h light and 12 h dark, temperature: 21Ϯ2°C) and fed with balanced diet and water ad libitum. 10) Analgetic activity of the compounds was assessed according to diStasi et al. 12) Test compounds were dissolved in water or DMSO (vehicle) for injection and administered intramuscularly at a dose of 50 mg/kg body weight. Pethidine (50 mg/kg) was used as a standard drug and the control groups received only the vehicle. Readings were taken at 30, 60, 90, 120, 150 and 180 min after administration of the compounds. The tail flick latency difference (TFLD) after compound administration was used to mea- sure the analgesia produced by the test compounds and the standard drug.
Determination of Mean Arterial Blood Pressure
Male Wistar rats (200-250 g) were used for the determination of mean arterial blood pressure (MABP). 13, 14) The animals were anesthetized with an intraperitoneal injection of thiopentone (pentothal, 70-90 mg/kg body weight). The right carotid artery was cannulated with heparinized polyethylene tubing (PE-50) connected to a pressure transducer coupled with a Grass 7D model polygraph. The left jugular vein was cannulated with a similar tubing to facilitate the intravenous injection of the drugs and test compounds. The rats were injected with heparin (1000 mg/kg body weight) to prevent blood clotting. After a 20 min period of equilibrium, the rats were injected intravenously with 0.2 ml saline (NaCl 0.9%) or with the same volume of test substance. Arterial blood pressure was allowed to return to the resting level between injections. Changes in blood pressure were recognized as the differences between the steady state values before and the lowest readings after injection. Mean blood pressure was calculated as the diastolic blood pressure plus onethird-pulse width.
General Procedure for the Preparation of Compounds 2-5 Equimolar quantities of 4-(4Ј-chlorophenyl)-4-hydroxypiperidine (1) and various substituted phenacyl halides were dissolved in approximately 50 ml ethanol in separate conical flasks and mixed together. The reaction mixture was stirred at room temperature for 4-8 h, followed by refluxing on a water bath until completion of the reaction. The solid precipitate was filtered and washed with appropriate solvents to remove the unreacted starting materials. The product was recrystalized from appropriate solvents to give the purified product.
1-(3Љ,4Љ-Dihydroxyphenacyl)-4-(4Ј-chlorophenyl)-4-hydroxypiperidinium Hydrochloride (2): Colorless crystalline powder (300 g, 83% 
